Showing results 1 to 15 of 15
A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectin Saw, Phei Er; Park, Jinho; Jon, Sangyong; Farokhzad, Omid C., NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, v.13, no.2, pp.713 - 722, 2017-02 |
Assessment of siRNA pharmacokinetics using ELISA-based quantification Kim, Eun-Joong; Park, Tae Gwan; Oh, Yu-Kyoung; Shim, Chang-Koo, JOURNAL OF CONTROLLED RELEASE, v.143, no.1, pp.80 - 87, 2010-04 |
Dual gene targeted multimeric siRNA for combinatorial gene silencing Lee, Soo-Hyeon; Mok, Hye-Jung; Jo, Sung-Duk; Hong, Cheol-Am; Park, Tae-Gwan, BIOMATERIALS, v.32, no.9, pp.2359 - 2368, 2011-03 |
Efficient Functional Delivery of siRNA using Mesoporous Silica Nanoparticles with Ultralarge Pores Na, Hee-Kyung; Kim, Mi-Hee; Park, Ki-Hyun; Ryoo, Soo-Ryoon; Lee, Kyung-Eun; Jeon, Hye-Sung; Ryoo, Ryong; et al, SMALL, v.8, no.11, pp.1752 - 1761, 2012-06 |
Efficient Liposomal Nanocarrier-mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell-Penetrating Peptide as a Packaging and Intracellular Delivery Agent Saw, Phei Er; Ko, Young Tag; Jon, Sangyong, MACROMOLECULAR RAPID COMMUNICATIONS, v.31, pp.1155 - 1162, 2010-07 |
Gene silencing efficiency of siRNA-PEG conjugates: Effect of PEGylation site and PEG molecular weight Jung, Soo-Yeon; Lee, Soo-Hyeon; Mok, Hye-Jung; Chung, Hyun-Jung; Park, Tae-Gwan, JOURNAL OF CONTROLLED RELEASE, v.144, no.3, pp.306 - 313, 2010-06 |
Hybrid Polymeric Nanomaterials for siRNA Delivery and Imaging Mok, Hyejung; Park, Tae Gwan, MACROMOLECULAR BIOSCIENCE, v.12, no.1, pp.40 - 48, 2012 |
Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer Kim, Sun Hwa; Jeong, Ji Hoon; Lee, Soo Hyeon; Kim, Sung Wan; Park, Tae Gwan, JOURNAL OF CONTROLLED RELEASE, v.129, no.2, pp.107 - 116, 2008-07 |
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy Kim, Sun-Hwa; Jeong, Ji-Hoon; Lee, Soo-Hyeon; Kim, Sung-Wan; Park, Tae-Gwan, JOURNAL OF CONTROLLED RELEASE, v.116, no.2, pp.123 - 129, 2006 |
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery![]() Kim, Byungji; Park, Ji-Ho; Sailor, Michael J., ADVANCED MATERIALS, v.31, no.49, pp.1903637, 2019-12 |
siRNA Conjugate Delivery Systems Jeong, Ji Hoon; Mok, Hyejung; Oh, Yu-Kyoung; Park, Tae Gwan, BIOCONJUGATE CHEMISTRY, v.20, no.1, pp.5 - 14, 2009-11 |
siRNA delivery systems for cancer treatment Oh, Yu-Kyoung; Park, Tae Gwan, ADVANCED DRUG DELIVERY REVIEWS, v.61, no.10, pp.850 - 862, 2009-08 |
Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine) Kim, SH; Jeong, JH; Cho, KC; Kim, SW; Park, TG, JOURNAL OF CONTROLLED RELEASE, v.104, no.1, pp.223 - 232, 2005-05 |
VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide Lee, Young Woong; Hwang, Young Eun; Lee, Ju Young; Sohn, Jung-Hoon; Sung, Bong Hyun; Kim, Sun Chang, JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, v.28, no.3, pp.367 - 374, 2018-03 |
Where should siRNAs go: applicable organs for siRNA drugs Ahn, Insook; Kang, Chanhee S.; Han, Jinju, EXPERIMENTAL AND MOLECULAR MEDICINE, v.55, no.7, pp.1283 - 1292, 2023-07 |
Discover